Company: LCTX
Filing Date: 2025-05-13
Form Type: 8-K
Source: 0000950170-25-070337
Chunk: 1

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-05-13
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
         99.1      Press release issued May 13, 2025                                            
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                           Lineage Cell Therapeutics, Inc.          
  Date:      May 13, 2025      By:         /s/ George A. Samuel III                 
                               Name:       George A. Samuel III